36 related articles for article (PubMed ID: 15536333)
1. Estrogen and progesterone receptor expression in uterine and extrauterine leiomyosarcomas: an immunohistochemical study.
Kelley TW; Borden EC; Goldblum JR
Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):338-41. PubMed ID: 15536333
[TBL] [Abstract][Full Text] [Related]
2. Phase 2 study of anastrozole in rare cohorts of patients with estrogen receptor/progesterone receptor positive leiomyosarcomas and carcinosarcomas of the uterine corpus: The PARAGON trial (ANZGOG 0903).
Edmondson RJ; O'Connell RL; Banerjee S; Mileshkin L; Sykes P; Beale P; Fisher A; Bonaventura A; Millan D; Nottley S; Benson C; Hamilton A; Sjoquist K; Alexander L; Kelly C; Carty K; Divers L; Bradshaw N; Friedlander M;
Gynecol Oncol; 2021 Dec; 163(3):524-530. PubMed ID: 34625284
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of hormone receptors with predictive value in mammary carcinomas.
Pleşan DM; Georgescu CV; Ciobotea S; Pătrană N; Mitroi L; Pleşan C
Curr Health Sci J; 2009 Jul; 35(3):184-9. PubMed ID: 24778819
[TBL] [Abstract][Full Text] [Related]
4. Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas.
Nakazawa MS; Silverman IM; Rimkunas V; Veloso A; Glodzik D; Johnson A; Ohsumi TK; Patel SR; Conley AP; Roland CL; Soliman PT; Beird HC; Wu CC; Ingram DR; Lazcano R; Song D; Wani KM; Lazar AJ; Yap TA; Wang WL; Livingston JA
Mol Cancer Ther; 2024 Apr; ():. PubMed ID: 38561019
[TBL] [Abstract][Full Text] [Related]
5. Progesterone Receptor Expression Is an Independent Prognosticator in FIGO Stage I Uterine Leiomyosarcoma.
Davidson B; Kjæreng ML; Førsund M; Danielsen HE; Kristensen GB; Abeler VM
Am J Clin Pathol; 2016 Apr; 145(4):449-58. PubMed ID: 27149024
[TBL] [Abstract][Full Text] [Related]
6. A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis.
Kim K; Kim S; Ahn T; Kim H; Shin SJ; Choi CH; Park S; Kim YB; No JH; Suh DH
BMC Cancer; 2023 Dec; 23(1):1215. PubMed ID: 38066476
[TBL] [Abstract][Full Text] [Related]
7. Locally advanced solitary fibrous tumour of the prostate.
Wahlstedt E; Zhou C; Strup S; Kyung Kim J; Strup SE; Yenwong L; Allison DB; Hensley PJ
BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37848277
[TBL] [Abstract][Full Text] [Related]
8. Updates in Pathology for Retroperitoneal Soft Tissue Sarcoma.
Mack T; Purgina B
Curr Oncol; 2022 Sep; 29(9):6400-6418. PubMed ID: 36135073
[TBL] [Abstract][Full Text] [Related]
9. Descriptive epidemiology of soft tissue sarcomas and gastrointestinal stromal tumors in Thailand.
Klangjorhor J; Pongnikorn D; Sittiju P; Phanphaisarn A; Chaiyawat P; Teeyakasem P; Kongdang P; Moonmuang S; Waisri N; Daoprasert K; Wisanuyotin T; Santong C; Sitthikong S; Tuntarattanapong P; Prechawittayakul P; Pruksakorn D
Sci Rep; 2022 Jul; 12(1):12824. PubMed ID: 35896585
[TBL] [Abstract][Full Text] [Related]
10. Role of Homologous Recombination Repair (HRR) Genes in Uterine Leiomyosarcomas: A Retrospective Analysis.
Ciccarone F; Bruno M; De Paolis E; Piermattei A; De Bonis M; Lorusso D; Zannoni GF; Normanno N; Minucci A; Scambia G; Ferrandina G
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454841
[TBL] [Abstract][Full Text] [Related]
11. Interrogating the Genomic Landscape of Uterine Leiomyosarcoma: A Potential for Patient Benefit.
Dall GV; Hamilton A; Ratnayake G; Scott C; Barker H
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326717
[TBL] [Abstract][Full Text] [Related]
12. Primary intracranial smooth muscle tumor associated with Epstein-Barr virus in immunosuppressed children: two cases report and review of literature.
Paez-Nova M; Andaur K; García-Ballestas E; Bustos-Salazar D; Moscote-Salazar LR; Koller O; Valenzuela S
Childs Nerv Syst; 2021 Dec; 37(12):3923-3932. PubMed ID: 33884483
[TBL] [Abstract][Full Text] [Related]
13. Hormone Replacement Therapy in Cancer Survivors - Review of the Literature.
Deli T; Orosz M; Jakab A
Pathol Oncol Res; 2020 Jan; 26(1):63-78. PubMed ID: 30617760
[TBL] [Abstract][Full Text] [Related]
14.
Seligson ND; Kautto EA; Passen EN; Stets C; Toland AE; Millis SZ; Meyer CF; Hays JL; Chen JL
Oncologist; 2019 Jul; 24(7):973-979. PubMed ID: 30541756
[TBL] [Abstract][Full Text] [Related]
15. A randomized phase II study of letrozole vs. observation in patients with newly diagnosed uterine leiomyosarcoma (uLMS).
Slomovitz BM; Taub MC; Huang M; Levenback C; Coleman RL
Gynecol Oncol Rep; 2019 Feb; 27():1-4. PubMed ID: 30519622
[TBL] [Abstract][Full Text] [Related]
16. Malignant tumors of the uterine corpus: molecular background of their origin.
Brany D; Dvorska D; Nachajova M; Slavik P; Burjanivova T
Tumour Biol; 2015 Sep; 36(9):6615-21. PubMed ID: 26307392
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical panel to differentiate endometrial stromal sarcoma, uterine leiomyosarcoma and leiomyoma: something old and something new.
Hwang H; Matsuo K; Duncan K; Pakzamir E; Pham HQ; Correa A; Fedenko A; Mhawech-Fauceglia P
J Clin Pathol; 2015 Sep; 68(9):710-7. PubMed ID: 25991737
[TBL] [Abstract][Full Text] [Related]
18. Multi-platform profiling of over 2000 sarcomas: identification of biomarkers and novel therapeutic targets.
Movva S; Wen W; Chen W; Millis SZ; Gatalica Z; Reddy S; von Mehren M; Van Tine BA
Oncotarget; 2015 May; 6(14):12234-47. PubMed ID: 25906748
[TBL] [Abstract][Full Text] [Related]
19. Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas.
Hensley ML; Barrette BA; Baumann K; Gaffney D; Hamilton AL; Kim JW; Maenpaa JU; Pautier P; Siddiqui NA; Westermann AM; Ray-Coquard I
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S61-6. PubMed ID: 25341583
[TBL] [Abstract][Full Text] [Related]
20. Incidence, and gender, age and ethnic distribution of sarcomas in the republic of suriname from 1980 to 2008.
Mans DR; Budhu Lall AE; Macnack VL; van Tholl JA; Zandveld EB; Vrede MA
West Indian Med J; 2014 Mar; 63(2):121-7. PubMed ID: 25303244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
